{"title":"Liraglutide results in significant weight loss in patients with bipolar disorder","authors":"","doi":"10.1002/pu.31179","DOIUrl":null,"url":null,"abstract":"<p>A 40-week study has found that obese or overweight individuals with stable bipolar disorder who received liraglutide lost significantly more body weight than individuals receiving placebo. Liraglutide was associated with few adverse events and no exacerbation of psychopathology.</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Brown University Psychopharmacology Update","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/pu.31179","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
A 40-week study has found that obese or overweight individuals with stable bipolar disorder who received liraglutide lost significantly more body weight than individuals receiving placebo. Liraglutide was associated with few adverse events and no exacerbation of psychopathology.